One Big Question Podcast-"THE NEXT BIG CONVERSATION IN WEIGHT MANAGEMENT? RETATRUTIDE."

Podcast: The Heat 94.6 Radio Station®️ · Kennedy Lucas Patterson

Opublikowano: 2026-09-01

One Big Question Podcast 🚨 THE NEXT BIG CONVERSATION IN WEIGHT MANAGEMENT? RETATRUTIDE. 🚨 The science around metabolic health is moving FAST — and one investigational medication getting serious attention is retatrutide, being developed by Eli Lilly. Unlike traditional GLP-1 medications, retatrutide is designed to activate three hormone pathways: GIP, GLP-1 and glucagon. And Lilly’s Phase 3 clinical-trial program is producing some eye-opening results. In the TRIUMPH-1 Phase 3 trial, participants receiving the 12 mg dose experienced an average 28.3% reduction in body weight at 80 weeks. Lilly also reported that 45.3% of participants receiving 12 mg achieved a...